Showing results (1-10 of 88) with videos related to
Sort By:
Pageof 9
Current Pharmaceutical Design|December 25, 2009
Emerging peptide therapeutics for inflammatory autoimmune diseasesJean-Paul Briand, Sylviane MullerMethods in Molecular Biology (Clifton, N.J.)|February 6, 2014
Generation of self-peptides to treat systemic lupus erythematosusJean-Paul Briand, Nicolas Schall, Sylviane MullerJournal of Immunological Methods|March 1, 2003
How biotinylation can interfere with recognition: a surface plasmon resonance study of peptide-antibody interactionsJean-Christophe Peter, Jean-Paul Briand, Johan HoebekeThe Journal of Organic Chemistry|May 25, 2002
Methyl 2-((succinimidooxy)carbonyl)benzoate (MSB): a new, efficient reagent for N-phthaloylation of amino acid and peptide derivativesJ Richard Casimir, Gilles Guichard, Jean-Paul BriandArthritis Research & Therapy|October 30, 2007
Importance of spliceosomal RNP1 motif for intermolecular T-B cell spreading and tolerance restoration in lupusFanny Monneaux, Véronique Parietti, Jean-Paul Briand, et al.Chemical Communications (Cambridge, England)|January 23, 2004
Translocation of bioactive peptides across cell membranes by carbon nanotubesDavide Pantarotto, Jean-Paul Briand, Maurizio Prato, et al.Vascular Cell|December 26, 2012
The pseudopeptide HB-19 binds to cell surface nucleolin and inhibits angiogenesisCharalampos Birmpas, Jean Paul Briand, Josẻ Courty, et al.Arthritis and Rheumatism|October 12, 2004
Intramolecular T cell spreading in unprimed MRL/lpr mice: importance of the U1-70k protein sequence 131-151Fanny Monneaux, Véronique Parietti, Jean-Paul Briand, et al.BMC Cell Biology|November 14, 2012
Nucleolin mediates the antiangiogenesis effect of the pseudopeptide N6LCharalampos Birmpas, Jean Paul Briand, Josẻ Courty, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2002
T cell response to preproinsulin I and II in the nonobese diabetic mousePhilippe Halbout, Jean-Paul Briand, Chantal Bécourt, et al.Pageof 9